MKC 72.69 Mccormick & Company Inc $MKC Hit a 52 week high

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
MKC 72.69 Mccormick & Company Inc $MKC Hit a 52 week high of 72.96 Closing the day 09:45 at 72.69 -0.53 -0.72% With a day low of 72.49 and a total volume of 30,178.

MKC Recent Posts: http://investorshangout.com/Mccormick--Compan...MKC-51818/

MKC Mccormick & Company Inc Recent Headline News

Tracking The Parnassus Core Equity Fund
IVI Guy - at Seeking Alpha - Wed Nov 12, 6:45AM CST

WDFC: 77.32 (-0.34), SJR: 26.04 (-0.04), PRGO: 154.63 (-0.81), XYL: 37.50 (+0.15), CHRW: 72.45 (+0.70), MDLZ: 37.90 (+0.13), MKC: 73.04 (-0.18), MDU: 25.35 (-0.36), SYY: 38.86 (+0.34), PDCO: 44.81 (+0.54), PNR: 68.22 (+0.10), TRI: 38.08 (+0.16), UPS: 108.06 (-0.70), PEP: 97.28 (+0.58), AGN: 196.19 (+0.85), MSI: 63.70 (+0.15), NOV: 73.65 (+0.55), NWN: 46.84 (-0.65), EGN: 68.60 (-0.18), EBAY: 54.10 (-0.09), QCOM: 70.27 (+0.63), AMAT: 22.63 (+0.09), ACN: 83.97 (+0.03), AAPL: 110.96 (+1.26), MA: 84.49 (-0.10), SCHW: 28.84 (-0.01), STR: 23.79 (-0.50), SE: 38.95 (-0.38), GAS: 51.99 (-1.28), IRM: 37.98 (+0.15), WM: 49.46 (+0.10), CMP: 88.50 (+0.48), VRSK: 63.17 (+0.16), GILD: 107.14 (-0.87), EXPD: 44.16 (-0.10), TFX: 114.49 (+0.16), CVS: 89.37 (-0.39), PG: 89.60 (-0.07), PX: 126.22 (-0.48), NVS: 92.72 (-0.05)

Mondelez to Buy 80% Stake in Vietnamese Snack Company - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 6:01PM CST
Mondelez International, Inc. (MDLZ) recently announced its plans to buy majority stake in Kinh Do Corporation's snacks unit for $370 million.
MDLZ: 37.90 (+0.13), MKC: 73.04 (-0.18), CAG: 34.56 (+0.36), KRFT: 57.55 (-0.33)

Sysco Expands; Buys Pacific Star Foodservice in Mexico - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 3:10PM CST
Last week, Sysco Corp. (SYY) inked an agreement to buy 50% of Pacific Star Foodservice but the financial details of the deal were not disclosed.
HAIN: 106.02 (+0.47), POST: 37.01 (+0.10), MKC: 73.04 (-0.18), SYY: 38.86 (+0.34)

ConAgra Hits 52-Week High on Healthy Q1 Earnings Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 2:10PM CST
Shares of North American food company ConAgra Foods, Inc. (CAG) hit a new 52-week high of $34.92 on Nov 7.
HAIN: 106.02 (+0.47), MKC: 73.04 (-0.18), CAG: 34.56 (+0.36), MED: 30.02 (+0.48)

General Mills Shares Dip 3.6% on 2015 Guidance Cut - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 1:52PM CST
General Mills Inc. (GIS) cuts its earnings and revenue expectations for fiscal 2015.
HAIN: 106.02 (+0.47), MKC: 73.04 (-0.18), CAG: 34.56 (+0.36), GIS: 50.87 (-0.10)

Treehouse Foods (THS) Crumbles: Stock Falls by 6.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 7:43AM CST
Treehouse Foods'shares dropped 6% friday , continuing the recent trend as the stock is now up around 1.4% since Oct 17.
HAIN: 106.02 (+0.47), MKC: 73.04 (-0.18), CAG: 34.56 (+0.36), THS: 82.85 (+1.69)

Hain Celestial Q1 Earnings Beat Estimates, Outlook Intact - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 8:00AM CST
The Hain Celestial Group, Inc. (HAIN) started fiscal 2015 on a strong note as the company's first quarter yielded historically high revenues and adjusted earnings.
HAIN: 106.02 (+0.47), POST: 37.01 (+0.10), MKC: 73.04 (-0.18), CAG: 34.56 (+0.36)

McCormick Names Mike Smith Senior Vice President Finance - Capital Markets and Chief Financial Officer of North America
PR Newswire - Thu Nov 06, 2:07PM CST
McCormick & Company, Incorporated (NYSE: MKC), a global leader in flavor, today announced the appointment of Mike Smith to the role of Senior Vice President Finance - Capital Markets and Chief Financial Officer (CFO) North America. This promotion was effective October 1, 2014.
MKC: 73.04 (-0.18)

Molson Coors Lags Q3 Earnings, Revenues on Low Volumes - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 10:01AM CST
Global brewer Molson Coors Brewing Company (TAP) posted adjusted earnings of $1.46 per share in the third quarter of 2014, missing the Zacks Consensus Estimate of $1.50 per share by 2.67%.
POST: 37.01 (+0.10), MKC: 73.04 (-0.18), SAM: 266.00 (+0.34), TAP: 75.41 (-0.80)

Halyard Health Debuts After Spin-Off from Kimberly-Clark - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 2:47PM CST
Halyard Health Inc. (HYH), a global medical technology company, has begun trading on the New York Stock Exchange from Nov 3 after it was spun-off from Kimberly-Clark Corporation (KMB) on Oct 31.
HAIN: 106.02 (+0.47), UNFI: 73.82 (+0.50), MKC: 73.04 (-0.18), KMB: 113.45 (+0.08)

Upgrade Alert for McCormick & Co (MKC)
Comtex SmarTrend(R) - Tue Nov 04, 7:03AM CST
McCormick & Co (NYSE:MKC) was upgraded from Market Perform to Outperform at Bernstein today. The stock closed yesterday at $71.13 on volume of 523,000 shares, below average daily volume of 812,000. Potential upside of 1.8% exists for McCormick & Co, based on a current level of $71.13 and analysts' average consensus price target of $72.43. The stock should find initial support at its 200-day moving average (MA) of $69.09 and further support at its 50-day MA of $68.30.
MKC: 73.04 (-0.18)

Sysco Beats Q1 Earnings on Volume Growth, Acquisitions - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 9:58AM CST
Sysco Corporation (SYY) reported first-quarter fiscal 2015 adjusted earnings of 52 cents. Earnings beat the Zacks Consensus Estimate of 50 cents by 4% and also increased 6.1% year over year as an improvement in sales made up for the ongoing cost pressure.
HAIN: 106.02 (+0.47), POST: 37.01 (+0.10), MKC: 73.04 (-0.18), SYY: 38.86 (+0.34)

What Makes Boulder Brands (BDBD) a Strong Sell? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 7:49AM CST
Boulder Brands has been witnessing a negative trend in its earnings estimate and its share price has been falling for past 1 month
HAIN: 106.02 (+0.47), MKC: 73.04 (-0.18), CAG: 34.56 (+0.36), BDBD: 9.22 (unch)

The New Nifty Fifty, Part 3: Dividend Growth Ideas And Valuations
Mike Nadel - at Seeking Alpha - Thu Oct 30, 4:32PM CDT

MAIN: 32.30 (+0.12), MKC: 73.04 (-0.18), HSY: 96.41 (-0.06), GPC: 100.07 (+0.41), UTX: 107.98 (-0.28), NOC: 136.11 (-0.74), WMT: 79.37 (+0.36), KRFT: 57.55 (-0.33), TGT: 66.57 (+0.85), DE: 88.10 (-0.35), COST: 137.01 (-0.04), CAT: 102.88 (+0.35), MSFT: 48.86 (-0.01), MA: 84.49 (-0.10), NSC: 116.66 (+0.03), COP: 71.56 (-0.19), WFC: 53.47 (-0.11), MO: 49.27 (-0.01), ADP: 85.52 (+0.57), AVA: 34.17 (-0.76), MCD: 95.21 (+0.07), CVX: 118.20 (-0.24), GIS: 50.87 (-0.10), D: 72.32 (-1.59), KMI: 38.57 (+0.03), MMM: 157.51 (+0.40), GE: 26.53 (+0.15), BDX: 129.08 (+0.32), LMT: 187.12 (unch), CLX: 101.55 (+0.20), MDT: 68.63 (-0.36), RTN: 103.62 (-0.12), KMB: 113.45 (+0.08), XOM: 95.82 (-0.59), O: 46.37 (-0.46), WEC: 48.16 (-1.57), SJM: 100.37 (-4.35), PEP: 97.27 (+0.57), SBUX: 77.89 (+0.16), T: 35.36 (+0.26), JNJ: 108.87 (-0.04), V: 251.43 (+1.70), IBM: 162.25 (-1.05), QCOM: 70.27 (+0.63), AAPL: 110.96 (+1.26), ACN: 83.97 (+0.03), WAG: 67.30 (-0.20), KO: 42.82 (+0.31), HCP: 43.19 (-0.18), HCN: 70.79 (-0.05), EMR: 64.21 (-0.35), DIS: 89.88 (-0.10), SO: 46.90 (-0.68), NEE: 102.77 (-2.03), PM: 88.00 (-0.09), BAX: 71.01 (+0.25), OHI: 37.78 (-0.03), PG: 89.60 (-0.07), VZ: 50.97 (+0.36), AFL: 59.17 (+0.13), CL: 68.67 (+0.20)

Kellogg's Q3 Earnings Beat by a Penny, Sales Remain Weak - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 9:16AM CDT
Kellogg Company (K) reported better-than-expected earnings and profits in the third quarter of 2014. However, sales continued to decline as cereal sales in developed markets remained challenging.
POST: 37.01 (+0.10), MKC: 73.04 (-0.18), CAG: 34.56 (+0.36), K: 63.65 (-0.10)

Hershey Lags Q3 Earnings on High Dairy Costs; Cuts FY View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 1:10PM CDT
The Hershey Company (HSY) reported dismal third-quarter 2014 results following a weak first-half performance.
POST: 37.01 (+0.10), MKC: 73.04 (-0.18), CAG: 34.56 (+0.36), HSY: 96.41 (-0.06)

Spices and Herbs: Improving Public Health Through Flavorful Eating -- A Call to Action
PR Newswire - Tue Oct 28, 7:00AM CDT
Spices and herbs can play a significant role in improving America's health by helping to reduce sodium, calorie and fat intake while making healthy eating more appealing, conclude the authors of a scientific supplement published this month in the peer-reviewed journal Nutrition Today.
MKC: 73.04 (-0.18)

Expected Dividend Increases In November
Dividend Diplomats - at Seeking Alpha - Mon Oct 27, 9:34PM CDT
I can’t believe this, but there are only two months remaining in 2014. Holy cow has it been a great year. As October turns to November, we will once again review which companies we expect to announce dividend increases in November. For those of...
AEP: 56.80 (-1.14), BDX: 129.08 (+0.32), ADP: 85.52 (+0.57), V: 251.43 (+1.70), CTAS: 71.25 (+0.15), MKC: 73.04 (-0.18), SYY: 38.86 (+0.34), EMR: 64.21 (-0.35), VFC: 71.04 (+0.52), HRL: 54.67 (-0.08), AFL: 59.17 (+0.13), BF.B: 93.85 (-0.30)

Unilever (UL) Posts Yet Another Weak Quarter, Shares Decline - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 10:10AM CDT
Unilever Plc (UL) reported its third quarter 2014 results on Oct 23, and its operations were hurt by macro-economic headwinds. Shares of Unilever declined 3.31% following the earnings announcement.
HAIN: 106.02 (+0.47), POST: 37.01 (+0.10), MKC: 73.04 (-0.18), UL: 40.43 (-0.31)

P&G Misses Q1 Earnings on Flat Volumes, Currency Impact - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 9:27AM CDT
The Procter & Gamble Company (PG) reported weak fiscal first-quarter 2015 results missing the Zacks Consensus Estimate for both earnings and sales.
HAIN: 106.02 (+0.47), POST: 37.01 (+0.10), MKC: 73.04 (-0.18), PG: 89.60 (-0.07)

Mccormick & Company Inc. (MKC) Stock Research Links

MKC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 188

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 296

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 319

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 240

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 283

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 462

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 597

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 235

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 81

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 246

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading

Top 5 Most Recently Viewed Articles

New Partnership Expands Eco-Friendly Solutions in the South

Updated Category News Views 234

Expanding Environmental Solutions in the Southern States Easy Environmental Solutions Inc., formerly known as Digital Utilities Ventures, is excited to announce a significant partnership with Organic Living Soil, LLC. As the exclusive dealer for Easy Environmental Solutions in Louisiana and Mississippi, Organic Living Soil aims to revolutionize the way eco-friendly...

Continue Reading
Michael Young Enhances Ty J. Young Wealth Management Team

Updated Category News Views 244

Michael Young Joins Ty J. Young Wealth Management Ty J. Young Wealth Management, a prominent name in financial services, proudly announces the appointment of Michael Young as Vice President of Business Development. With a wealth of experience from his previous role as a sales executive in a Fortune 500 company, Young is set to take the lead in expanding the firm's...

Continue Reading
Johnson & Johnson Advances Myeloma Treatment with FDA Application

Updated Category News Views 289

Johnson & Johnson took a big swing back in 2024 when they submitted a supplemental Biologics License Application (sBLA) for their myeloma treatment, DARZALEX FASPRO®. This move aimed at getting the green light from the FDA for use among newly diagnosed multiple myeloma patients who couldn't go through autologous stem cell transplants. Desks buzzed with chatter on how...

Continue Reading
What Investors Should Anticipate in ScanSource's Earnings Report

Updated Category News Views 121

ScanSource's Earnings Report: Expectations and Insights ScanSource (NASDAQ:SCSC) is gearing up to release its quarterly earnings report soon. Investors are particularly interested in the results that are expected to be announced shortly. With the anticipation building, understanding what to look for is essential. Predicted Earnings Results Industry experts have estimated...

Continue Reading
Revealing the Truth: IRS Data Access by Immigration Authorities

Updated Category News Views 127

IRS Data Accessed by Immigration Authorities: An Overview Federal immigration officials gained access to taxpayer information from the IRS during the previous administration's deportation efforts, though they claim this data was not used to identify individuals for removal. This raises serious questions surrounding privacy and immigration enforcement. Cross-Referencing...

Continue Reading